openPR Logo
Press release

Global Antithrombotic Drugs Market US$ 27.5 Billion by 2021

02-05-2018 04:19 PM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Global Antithrombotic Drugs Market US$ 27.5 Billion by 2021

The global antithrombotic drugs market expected to reach US$ 27.5 billion by 2021, growing at CAGR 1.9% over the forecast period 2017-2021.

Antithrombotic drugs in routine use include antiplatelet drugs (aspirin, clopidogrel, and glycoprotein IIb/IIIa receptor antagonists) and anticoagulants (unfractionated and low molecular weight heparin, warfarin, and direct thrombin inhibitors). The use of antithrombotic therapy in acute coronary syndromes has reduced the incidence of death and Q wave myocardial infarction dramatically in recent years. Antithrombotic drugs are categorized into three broad types: platelet aggregation inhibitors (PAIs), fibrinolytics and anticoagulants. Antithrombotic therapy has reduced the risk of blood clots in leg veins (also known as deep-vein thrombosis or DVT), a condition that can lead to death from pulmonary embolism by more than 70 percent. And most importantly, it has markedly reduced death from heart attacks, the risk of stroke in people with heart irregularities (atrial fibrillation), and the risk of major stroke in patients with mini-strokes.

Visit Antithrombotic Drugs Market by Drug Type - Platelet Aggregation Inhibitors (PAIs); Fibrinolytics; Anticoagulants - Low-Molecular-Weight Heparins (LMWHs), Vitamin K Antagonists (VKAs), Direct Thrombin Inhibitors (DTIs), Direct Factor Xa Inhibitors (FXa); Other Antithrombotic Agents and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/antithrombotic-drugs-market/

The global antithrombotic drugs market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global antithrombotic drugs market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global antithrombotic drugs market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.

Major players operating in the global antithrombotic drugs market and profiled in this report include Armetheon, Armetheon, Bayer, Boehringer Ingelheim, Bristol-Myers Squib, Daiichi Sankyo, D Pharm, Endotis Pharma, Janssen, Lundbeck, Merck & Co., Pfizer, Portola Pharmaceuticals, Regado Biosciences, Roche, TeaRx, and The Medicines Company.

1. Drug Type
1.1. Platelet Aggregation Inhibitors (PAIs)
1.2. Fibrinolytics
1.3. Anticoagulants
1.3.1. Low-Molecular-Weight Heparins (LMWHs)
1.3.2. Vitamin K Antagonists (VKAs)
1.3.3. Direct Thrombin Inhibitors (DTIs)
1.3.4. Direct Factor Xa Inhibitors (FXa)
1.4. Other Antithrombotic Agents

2. Geography
2.1. North America (U.S., Canada)
2.2. Latin America (Brazil, Mexico, Rest of LA)
2.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4. Asia Pacific (Japan, China, India, Rest of APAC)
2.5. Rest of the World

3. Company Profiles
3.1. Armetheon
3.2. Armetheon
3.3. Bayer
3.4. Boehringer Ingelheim
3.5. Bristol-Myers Squib
3.6. Daiichi Sankyo
3.7. D Pharm
3.8. Endotis Pharma
3.9. Janssen
3.10. Lundbeck
3.11. Merck & Co.
3.12. Pfizer
3.13. Portola Pharmaceuticals
3.14. Regado Biosciences
3.15. Roche
3.16. TeaRx
3.17. The Medicines Company

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/antithrombotic-drugs-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antithrombotic Drugs Market US$ 27.5 Billion by 2021 here

News-ID: 930837 • Views:

More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/ Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5.5 Billion by 2025
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and Services Market to US$ 73.2 Billion by 2023
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by

All 5 Releases


More Releases for Antithrombotic

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Antithrombotic management plan for cancer patients
In Germany Thrombosis occurs 470.000 timesevery year - as often as a new cancer is diagnosed. With 44.000 deadly lung artery embolisms every year, thrombosis is very dangerous. Around 30 independent risk factors are known. One of the more important risk factors seems to be the amount of intracirculatory tissue factor molecules which is brought into circulation bound to the circulating epithelial cells. Tissue factor is always active to start the
Global Antithrombotic Drugs Market Analysis & Future Industry Growth 2025
Qyresearchreports include new market research report "Global Antithrombotic Drugs Market Size,Status and Forecast 2025" to its huge collection of research reports. This report on the global Antithrombotic Drugs market is a thorough study that has been compiled by experienced and professional research analysis who are experts in the commerce of the field. The idea behind the development of this report is to help its targeted audiences, serving as an asset for
Global Antithrombotic Drugs Market Size, Status and Forecast 2022
This report studies the global Antithrombotic Drugs market, analyzes and researches the Antithrombotic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Sanofi Bayer Boehringer Ingelheim Genentech Eli Lilly Johnson & Johnson Medicines Company Pfizer Otsuka Reddys Laboratories Sample of this report is available upon request @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1307442&type=E Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Antithrombotic Drugs can be split
Antithrombotic Drugs Market Rises Higher by 2025
Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and
Growth Antithrombotic Drugs Market : 2017 - 2025
Thrombosis is may be defined as the formation of blood clot in the blood vessel or lumen part of the blood vessel. Formation of blood clots inside the blood vessel causes disruption of blood flow and it leads to cause death of cells. Deep vein thrombosis (DVT) is one type of thrombosis and it affects larger muscle of thigh. As a result, it causes pain, swelling in the leg and